Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocugen (OCGN) Shares Issued (2017 - 2025)

Ocugen (OCGN) has disclosed Shares Issued for 12 consecutive years, with $1.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Issued rose 55.76% year-over-year to $1.5 million, compared with a TTM value of $2.4 million through Dec 2025, up 150.53%, and an annual FY2025 reading of $19.9 million, down 48.51% over the prior year.
  • Shares Issued was $1.5 million for Q4 2025 at Ocugen, up from $981000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $128.6 million in Q4 2021 and bottomed at -$127.9 million in Q3 2021.
  • Average Shares Issued over 5 years is $14.1 million, with a median of $1.5 million recorded in 2025.
  • The sharpest move saw Shares Issued plummeted 579.13% in 2021, then skyrocketed 6031.25% in 2024.
  • Year by year, Shares Issued stood at $128.6 million in 2021, then plummeted by 93.45% to $8.4 million in 2022, then crashed by 99.81% to $16000.0 in 2023, then surged by 6031.25% to $981000.0 in 2024, then surged by 55.76% to $1.5 million in 2025.
  • Business Quant data shows Shares Issued for OCGN at $1.5 million in Q4 2025, $981000.0 in Q4 2024, and -$145000.0 in Q1 2024.